Two analysts have rated the stock with a sell rating, one has issued a ... Roche presently has a consensus rating of “Moderate Buy”. Shares of RHHBY stock opened at $43.36 on Thursday.

While the stock market has been selling off recently, one stock that has bucked the trend is Berkshire Hathaway ( BRK.B -1.32 ...

Alnylam Pharmaceuticals gains FDA approval for Amvuttra in ATTR-CM, boosting revenue prospects. Click here to read an ...

Sarepta Therapeutics (SRPT) stock drops 25% as the company reports a patient death linked to Elevidys, its gene therapy developed with Roche (RHHBY). Read more here.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. As clinical studies advance successfully, existing investors may benefit from holding RXRX for potential multi ...

On the other hand, Bill is still growing rapidly, with 22% year-over-year revenue growth in fiscal 2024 (which ended in June). The business has an 85% adjusted gross margin and a 17% adjusted ...